| CPRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CPRX Shares Outstanding History and CPRX YTD Return |
| CPRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+41.44% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CPRX Stock Price Chart |
| About Catalyst Pharmaceuticals Inc |
| Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s main US commercial product is FIRDAPSE® (amifampridine) Tablets 10 mg approved for the treatment of Lambert-Eaton myasthenic syndrome for adults and for children ages six and up. Co. has the US rights to FYCOMPA®(perampanel) CIII, a prescription medication used alone or with other medicines to treat focal onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat generalized tonic-clonic seizures in people with epilepsy aged 12 and older. We show 61 historical shares outstanding datapoints in our CPRX shares outstanding history coverage, used to compute CPRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CPRX market cap history over the course of time is important for investors interested in comparing CPRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CPRX versus a peer is one thing; comparing CPRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CPRX can fluctuate over the course of history. With this page we aim to empower investors researching CPRX by allowing them to research the CPRX market cap history. |
| CPRX Current Stock Quote |
 Free CPRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CPRX Share Performance |
| Market Cap Peers |
| Catalyst Pharmaceuticals (CPRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CRBP Market Cap History |
